BCX-9930

N/A

Report date: 2026/01/25 20:00:09
NME

Base Information

Drug NameBCX-9930
Drug Alias NameBCX-9930
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsC3 glomerulopathyHemoglobinuria, ParoxysmalGlomerulonephritis, Membranous +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaItalyHungary +[10
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemoglobinuria, Paroxysmal
Inactive IndicationsC3 glomerulopathyGlomerulonephritis, MembranousGlomerulonephritis, IGA

Other Information

ATC CodeN/A
Related LinksN/A